RAPT Therapeutics, Inc. (RAPT)

NASDAQ: RAPT · Real-Time Price · USD

0.8500

-0.0393 (-4.42%)

At close: Apr 10, 2025, 4:00 PM

0.8365

-0.0135 (-1.59%)

After-hours: Apr 10, 2025, 7:51 PM EDT

RAPT Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Net Income	-129.87	-116.8	-83.84	-69.2	-52.89	Upgrade
Depreciation & Amortization	1.2	1.22	1.05	1	1.12	Upgrade
Loss (Gain) From Sale of Investments	-2.81	-5.74	-0.3	1.27	0.5	Upgrade
Stock-Based Compensation	19.94	17.09	11.26	9.95	8.69	Upgrade
Other Operating Activities	2.34	1.68	2.39	0.26	-0.25	Upgrade
Change in Accounts Payable	-8.46	7.34	3.71	0.93	2.39	Upgrade
Change in Unearned Revenue	-	-	-1.53	-3.43	0.96	Upgrade
Change in Other Net Operating Assets	34.37	-1.84	-3.52	-1.8	-1.01	Upgrade
Operating Cash Flow	-83.3	-97.05	-70.77	-61.03	-40.49	Upgrade
Capital Expenditures	-0.12	-1.13	-0.85	-0.76	-0.4	Upgrade
Investment in Securities	52.82	105.26	-44.65	-80.59	-87.04	Upgrade
Investing Cash Flow	52.7	104.13	-45.49	-81.35	-87.44	Upgrade
Issuance of Common Stock	152.85	1.45	131.18	141.48	75.46	Upgrade
Financing Cash Flow	152.85	1.45	131.18	141.48	75.46	Upgrade
Net Cash Flow	122.26	8.53	14.92	-0.89	-52.47	Upgrade
Free Cash Flow	-83.42	-98.17	-71.62	-61.78	-40.89	Upgrade
Free Cash Flow Margin	-	-	-4689.98%	-1620.27%	-810.97%	Upgrade
Free Cash Flow Per Share	-2.05	-2.56	-2.20	-2.26	-1.69	Upgrade
Cash Income Tax Paid	-	-	-	-	0.99	Upgrade
Levered Free Cash Flow	-38.77	-54.19	-40	-34.44	-22.33	Upgrade
Unlevered Free Cash Flow	-38.77	-54.19	-40	-34.44	-22.33	Upgrade
Change in Net Working Capital	-25.28	-8.04	-2.15	1.38	-1.52	Upgrade

Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q